An intriguing finding of the present work is that administration of vildagliptin, a competitive inhibitor of DPPIV catalytic activity, not only inhibits the activity of DPPIV but also reduces the protein and mRNA-expression of the peptidase in the heart of HF rats. Here, DPP4 is linked to hydrops fetalis.